December 17, 2021 To: Physicians Prescribing Treatment for Nonmuscle Invasive Bladder Cancer (NMIBC) Until 2021, TICE BCG was the only strain available in Canada A second strain of BCG recently received conditional approval by Health Canada in 2021 and is available in the Canadian market: VERITY-BCG(TM)The past shortage of BCG is therefore resolved. The Medical AdvisoryRead more